Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib
BiotechTV - News
00:00
Why the atopic dermatitis data resonated
Richard Miller explains data consistency, novel mechanism, and Corvus's leadership in ITK inhibition.
Play episode from 00:19
Transcript
